vs
Side-by-side financial comparison of Broadway Financial Corp (BYFC) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
TriSalus Life Sciences, Inc. is the larger business by last-quarter revenue ($13.2M vs $9.4M, roughly 1.4× Broadway Financial Corp). Broadway Financial Corp runs the higher net margin — 1934.0% vs -73.9%, a 2007.8% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 10.1%). Broadway Financial Corp produced more free cash flow last quarter ($-13.0K vs $-2.5M). Over the past eight quarters, TriSalus Life Sciences, Inc.'s revenue compounded faster (43.0% CAGR vs 9.7%).
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
BYFC vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.4M | $13.2M |
| Net Profit | $1.0M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | — | -24.8% |
| Net Margin | 1934.0% | -73.9% |
| Revenue YoY | 10.1% | 59.8% |
| Net Profit YoY | -21.8% | 3.5% |
| EPS (diluted) | $0.02 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.4M | $13.2M | ||
| Q3 25 | $9.0M | $11.6M | ||
| Q2 25 | $8.1M | $11.2M | ||
| Q1 25 | $8.3M | $9.2M | ||
| Q4 24 | $8.6M | $8.3M | ||
| Q3 24 | $8.7M | $7.3M | ||
| Q2 24 | $8.2M | $7.4M | ||
| Q1 24 | $7.8M | $6.5M |
| Q4 25 | $1.0M | $-9.8M | ||
| Q3 25 | $-23.9M | $-10.8M | ||
| Q2 25 | $752.0K | $-8.3M | ||
| Q1 25 | $-2.7M | $-10.4M | ||
| Q4 24 | $1.3M | $-10.1M | ||
| Q3 24 | $516.0K | $-2.4M | ||
| Q2 24 | $256.0K | $-4.3M | ||
| Q1 24 | $-154.0K | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | — | -24.8% | ||
| Q3 25 | -256.2% | -77.9% | ||
| Q2 25 | 12.8% | -65.4% | ||
| Q1 25 | -45.3% | -79.9% | ||
| Q4 24 | 21.7% | -91.8% | ||
| Q3 24 | 8.5% | -118.9% | ||
| Q2 24 | 4.8% | -111.0% | ||
| Q1 24 | -2.9% | -180.8% |
| Q4 25 | 1934.0% | -73.9% | ||
| Q3 25 | -264.2% | -93.5% | ||
| Q2 25 | 9.3% | -73.9% | ||
| Q1 25 | -32.3% | -113.2% | ||
| Q4 24 | 15.3% | -122.4% | ||
| Q3 24 | 5.9% | -32.6% | ||
| Q2 24 | 3.1% | -58.8% | ||
| Q1 24 | -2.0% | -204.5% |
| Q4 25 | $0.02 | $-0.22 | ||
| Q3 25 | $-2.86 | $-0.96 | ||
| Q2 25 | $0.00 | $-0.27 | ||
| Q1 25 | $-0.39 | $-0.39 | ||
| Q4 24 | $0.07 | $-0.38 | ||
| Q3 24 | $-0.03 | $-0.12 | ||
| Q2 24 | $0.02 | $-0.21 | ||
| Q1 24 | $-0.02 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $262.8M | $-33.9M |
| Total Assets | $1.3B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $20.4M | ||
| Q3 25 | $19.7M | $22.7M | ||
| Q2 25 | $29.5M | $26.5M | ||
| Q1 25 | $15.8M | $13.0M | ||
| Q4 24 | $61.4M | $8.5M | ||
| Q3 24 | $97.1M | $11.3M | ||
| Q2 24 | $89.8M | $16.5M | ||
| Q1 24 | $67.1M | $4.0M |
| Q4 25 | $262.8M | $-33.9M | ||
| Q3 25 | $261.7M | $-26.7M | ||
| Q2 25 | $284.7M | $-19.4M | ||
| Q1 25 | $283.6M | $-34.4M | ||
| Q4 24 | $285.0M | $-25.9M | ||
| Q3 24 | $286.2M | $-20.4M | ||
| Q2 24 | $282.1M | $-25.3M | ||
| Q1 24 | $281.1M | $-36.0M |
| Q4 25 | $1.3B | $35.3M | ||
| Q3 25 | $1.3B | $36.5M | ||
| Q2 25 | $1.2B | $41.3M | ||
| Q1 25 | $1.3B | $28.6M | ||
| Q4 24 | $1.3B | $24.0M | ||
| Q3 24 | $1.4B | $27.5M | ||
| Q2 24 | $1.4B | $32.4M | ||
| Q1 24 | $1.4B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $230.0K | $-2.5M |
| Free Cash FlowOCF − Capex | $-13.0K | $-2.5M |
| FCF MarginFCF / Revenue | -0.1% | -19.1% |
| Capex IntensityCapex / Revenue | 2.6% | 0.3% |
| Cash ConversionOCF / Net Profit | 0.22× | — |
| TTM Free Cash FlowTrailing 4 quarters | $2.3M | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $230.0K | $-2.5M | ||
| Q3 25 | $3.8M | $-3.7M | ||
| Q2 25 | $3.0M | $-7.3M | ||
| Q1 25 | $-4.3M | $-4.5M | ||
| Q4 24 | $1.4M | $-5.7M | ||
| Q3 24 | $6.1M | $-10.8M | ||
| Q2 24 | $9.8M | $-13.4M | ||
| Q1 24 | $-11.7M | $-10.9M |
| Q4 25 | $-13.0K | $-2.5M | ||
| Q3 25 | $3.7M | $-3.9M | ||
| Q2 25 | $3.0M | $-7.4M | ||
| Q1 25 | $-4.4M | $-5.3M | ||
| Q4 24 | $1.3M | $-5.8M | ||
| Q3 24 | $6.1M | $-11.0M | ||
| Q2 24 | $9.7M | $-13.5M | ||
| Q1 24 | $-11.7M | $-10.9M |
| Q4 25 | -0.1% | -19.1% | ||
| Q3 25 | 41.1% | -33.9% | ||
| Q2 25 | 37.0% | -66.1% | ||
| Q1 25 | -52.4% | -57.3% | ||
| Q4 24 | 14.7% | -69.7% | ||
| Q3 24 | 69.6% | -149.9% | ||
| Q2 24 | 118.9% | -183.1% | ||
| Q1 24 | -149.7% | -169.3% |
| Q4 25 | 2.6% | 0.3% | ||
| Q3 25 | 1.2% | 1.9% | ||
| Q2 25 | 0.2% | 0.8% | ||
| Q1 25 | 0.2% | 8.2% | ||
| Q4 24 | 1.6% | 0.6% | ||
| Q3 24 | 0.3% | 2.3% | ||
| Q2 24 | 0.5% | 0.8% | ||
| Q1 24 | 0.7% | 1.0% |
| Q4 25 | 0.22× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 4.00× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.06× | — | ||
| Q3 24 | 11.85× | — | ||
| Q2 24 | 38.21× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
